Mobilizable Plasmids for Tunable Gene Expression in Francisella novicida. by Brodmann, M. et al.
ORIGINAL RESEARCH
published: 31 August 2018
doi: 10.3389/fcimb.2018.00284
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 August 2018 | Volume 8 | Article 284
Edited by:
Sophie Bleves,
Aix-Marseille Université, France
Reviewed by:
Gregory T. Robertson,
Colorado State University,
United States
Roger Derek Pechous,
University of Arkansas for Medical
Sciences, United States
*Correspondence:
Marek Basler
marek.basler@unibas.ch
Received: 08 May 2018
Accepted: 25 July 2018
Published: 31 August 2018
Citation:
Brodmann M, Heilig R, Broz P and
Basler M (2018) Mobilizable Plasmids
for Tunable Gene Expression in
Francisella novicida.
Front. Cell. Infect. Microbiol. 8:284.
doi: 10.3389/fcimb.2018.00284
Mobilizable Plasmids for Tunable
Gene Expression in Francisella
novicida
Maj Brodmann 1, Rosalie Heilig 2, Petr Broz 2 and Marek Basler 1*
1 Biozentrum, University of Basel, Basel, Switzerland, 2Department of Biochemistry, University of Lausanne, Épalinges,
Switzerland
Francisella tularensis is the causative agent of the life-threatening disease tularemia.
However, the molecular tools to study Francisella are limited. Especially, expression
plasmids are sparse and difficult to use, as they are unstable and prone to spontaneous
loss. Most Francisella expression plasmids lack inducible promoters making it difficult
to control gene expression levels. In addition, available expression plasmids are mainly
designed for F. tularensis, however, genetic differences including restriction-modification
systems impede the use of these plasmids in F. novicida, which is often used as
a model organism to study Francisella pathogenesis. Here we report construction
and characterization of two mobilizable plasmids (pFNMB1 and pFNMB2) designed
for regulated gene expression in F. novicida. pFNMB plasmids contain a tetracycline
inducible promoter to control gene expression levels and oriT for RP4 mediated
mobilization. We show that both plasmids are stably maintained in bacteria for more
than 40 generations over 4 days of culturing in the absence of selection against
plasmid loss. Expression levels are dependent on anhydrotetracycline concentration
and homogeneous in a bacterial population. pFNMB1 and pFNMB2 plasmids differ
in the sequence between promoter and translation start site and thus allow to reach
different maximum levels of protein expression. We used pFNMB1 and pFNMB2 for
complementation of Francisella Pathogenicity Island mutants 1iglF, 1iglI, and 1iglC
in-vitro and pFNMB1 to complement1iglImutant in bone marrow derived macrophages.
Keywords: Francisella novicida, expression plasmid, conjugation, ATc inducible, complementation, type VI
secretion system, bacterial mutagenesis, tularemia
INTRODUCTION
Francisella tularensis is the causative agent of tularemia and can cause life-threatening disease
in animals and humans. Essential for Francisella virulence is the Francisella pathogenicity island
(FPI), which encodes a dynamic type VI secretion system (T6SS) (Bröms et al., 2010; Chong and
Celli, 2010; Clemens et al., 2015; Brodmann et al., 2017). The most virulent subspecies F. tularensis
subspecies tularensis, classified as a Tier 1 agent (Oyston et al., 2004), and subspecies holarctica
(hereafter F. tularensis) contain two FPIs. The related subspecies F. tularensis subspecies novicida
(hereafter F. novicida) possesses only one FPI and is highly virulent in mice but rarely infects
humans. These features make F. novicida an ideal model organism for investigating tularemia and
Francisella T6SS (Kingry and Petersen, 2014).
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Molecular tools to make chromosomal in-frame deletion
mutations in Francisella are available and commonly used to
study the role of a certain gene of interest on a particular
phenotype (Anthony et al., 1991; Golovliov et al., 2003; Frank
and Zahrt, 2007). However, gene deletion and insertions may
alter the expression of neighboring genes and cause so called
“polar effects”. If expression of the gene of interest in trans
from an inducible plasmid reverses the mutant phenotype,
a possible polar effect can be ruled out. Unfortunately, only
few expression plasmids are available for Francisella. Therefore,
many recent studies lack in trans complementation of in-frame
deletion mutations (Nano and Schmerk, 2007; Santic et al., 2011;
Eshraghi et al., 2016; Brodmann et al., 2017) or use chromosomal
complementation in cis (de Bruin et al., 2007; Weiss et al., 2007;
Lindgren et al., 2013).
All available expression plasmids for Francisella are derived
from the pFNL10 plasmid except for pCUG18, which is derived
from pC194 and pUC18 (Rasko et al., 2007). pFNL10 was isolated
from the F. novicida-like strain F6168 (Pavlov et al., 1996). The
function of pFNL10 is unclear; however, the five encoding regions
on the plasmid were identified. ORF1—ORF3 are required for
plasmid replication and encode replication initiation protein
RepA (ORF1), an ATP-dependent RNA helicase/endonuclease
(ORF2), and an integrase/recombinase (ORF3). ORF4 and
ORF5 encode a putative toxin-antitoxin system together with a
possible regulatory feature ORFm (Pomerantsev et al., 2001a)
(Figure 1A). Over the last 20 years, pFNL10 was modified
to meet the needs of the Francisella research community.
First, tetracycline and chloramphenicol resistance cassettes were
introduced for selection resulting in pFNL200 (Pavlov et al.,
1996). Since pFNL200 was restricted to replicate in Francisella,
the p15A origin of replication of Escherichia coli was added
thus obtaining a shuttle vector pKK202 (Norqvist et al., 1996).
Later, the constitutively active groESL promoter was successfully
used to express gfp and other genes (pKK214, pKK289Km,
Figure 1B) in-vitro and in eukaryotic cells (Abd et al., 2003;
Bönquist et al., 2008). Other pFNL10 derivatives are pFNLTP,
which includes a version that only replicates at 32◦C but not
at 42◦C due to a mutation in repA (Maier et al., 2004) and
pMP, which includes a version of a bla promoter that is not
recognized in E. coli to allow cloning of toxic genes in E.
coli (LoVullo et al., 2006, 2009). So far, only two controllable
Francisella promoter systems exist; a glucose repressible system
(pTCD3) (Horzempa et al., 2008) and a tetracycline inducible
or repressible version of the groESL promoter (pEDL) (LoVullo
et al., 2012). The tetracycline inducible promoter system is a
preferred choice for many bacterial model organisms because
it allows tight and concentration dependent regulation of
expression levels. It is also applicable for infection models such
as cell cultures or animals since tetracycline passively penetrates
most mammalian membranes (Bertram and Hillen, 2008). The
tetracycline inducible promoter systems consists of constitutively
expressed TetR, which binds to the tetO sequence and thereby
transcriptionally represses the tetA promoter. Tetracycline or
anhydrotetracycline (ATc), which is less toxic but has even higher
affinity to TetR, binds TetR, and derepresses the tetA promoter
(Gossen and Bujard, 1992). In the case of the tetracycline
repressible promoter system, TetR binds tetO only if tetracycline
or ATc is present, therefore, transcription is repressed upon
addition of ATc (Scholz et al., 2004).
Despite the efforts in recent years, complementation from
plasmid remains difficult in Francisella. Non-native expression
levels (Santic et al., 2007; Zogaj and Klose, 2010) and spontaneous
deletions in pFNL200 (Pomerantsev et al., 2001b) and pFNLTP
(Maier et al., 2004) were reported. Another problem is the
relatively low electroporation efficiency in Francisella and
especially in F. novicida for plasmids isolated from E. coli. This
is thought to be due to active restriction-modification systems
in Francisella (Maier et al., 2004; LoVullo et al., 2006). In F.
novicida, 4 restriction-modification systems were identified to
restrict unmodified plasmid DNA, while in F. tularensis most
restriction-modification system were annotated as pseudogenes
(Gallagher et al., 2008). Expression plasmids were mainly tested
in F. tularensis (Norqvist et al., 1996; Abd et al., 2003; LoVullo
et al., 2006, 2009, 2012; Rasko et al., 2007) and consequently, in-
frame deletions were more often complemented from plasmid
in F. tularensis (Lai et al., 2004; Gil et al., 2006; Maier et al.,
2006; Bönquist et al., 2008; Ark and Mann, 2011; Lindemann
et al., 2011; Schmidt et al., 2013). On the other hand, suitable
expression plasmids are mostly lacking in F. novicida and
therefore only few studies include complementation experiments
(Tempel et al., 2006; de Bruin et al., 2011).
Here we report construction of expression plasmids derived
from pKK289Km specially designed for F. novicida. pFNMB1
and pFNMB2 plasmids can be mobilized by conjugation
to overcome the need for electroporation. In addition, ATc
induction allows homogeneous gene expression and the plasmids
are stably maintained in a population for 4 days without selection
pressure. As a proof of concept, we successfully complemented
in-frame deletion of FPI genes iglF, iglI, and iglC in-vitro and iglI
in bone marrow derived macrophages.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Francisella tularensis subsp. novicida strain U112 and the
derivative strains were grown in brain heart infusion (BHI)
broth supplemented with 0.2% L-cysteine (Sigma). Ampicillin
(100µg/ml, AppliChem) or kanamycin (15µg/ml, AppliChem)
were added if not stated otherwise. Liquid cultures were grown
aerobically at 37◦C. Gene expression from plasmid was induced
by adding the indicated concentration of anhydrotetracycline
(ATc, IBA) to the liquid culture at OD600 of 0.02 for 3 h.
Escherichia coli DH5α λpir and derivative strains were grown
aerobically in Luria broth (LB) or on LB agar plates both
supplemented with 50µg/ml kanamycin at 37◦C. All strains used
are listed in Supplementary Table 1.
Construction of Plasmids
All plasmids and corresponding primers are listed in
Supplementary Table 2. Expression plasmids pFNMB1 and
pFNMB2 were constructed by using the backbone of pKK289Km
gfp (Bönquist et al., 2008) and inserting the RP4 mobilization site
of pDMK3 (Lindgren et al., 2007) at EcoRI and SbfI restriction
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FIGURE 1 | Plasmid maps. Promoters, genes, terminators, and some relevant restriction sites are shown. Maps were designed with SnapGene Version 4.0.3. (A)
Plasmid map of pFNL10 according to Pomerantsev et al. (2001a). (B) Plasmid map of pKK289Km gfp according to Bönquist et al. (2008). (C) Plasmid map of pFNMB
msfgfp with variable RBS sequences. pFNMB1 contains the RBS sequence of iglC and pFNMB2 of pKK289Km. The underline highlights the RBS, the arrows mark
the MluI restriction site and the start codon is represented in bold.
sites, thereby removing the truncated chloramphenicol resistance
cassette, a leftover of pKK214CAT (Abd et al., 2003). Then the
ATc inducible promoter cassette of pEDL17 (tetR with rpsL
promoter and groESL promoter with tetO; LoVullo et al., 2012),
the multiple cloning site of pDMK3 and the E. coli rrnB T1
and T2 terminators of pBAD24 (Guzman et al., 1995) were
combined by overlap-extension PCR. The PCR product was
placed into pKK289Km gfp at SpeI and EcoRI restriction sites
to remove the original groESL promoter and gfp gene. For
pFNMB1, the iglC RBS was inserted together with msfgfp at
XhoI and XmaI restriction sites by amplification of msfgfp
with primers containing the sequence of iglC RBS and an
additional MluI restriction site in front of the msfgfp start
codon (AGAGGAGAACGCGT). For pFNMB2, the iglC RBS
was exchanged for the RBS of pKK289Km by combining the
ATc inducible promoter cassette of pEDL17 and msfgfp by
overlap-extension PCR using primers containing the RBS of
pKK289Km with a MluI restriction site. The PCR product was
placed into pFNMB1 at SpeI and XmaI restriction sites. All
cloning products were sequenced. Plasmid maps were generated
with SnapGene Version 4.0.3. pFNMB1 msfgfp (Addgene ID:
113191) and pFNMB2 msfgfp (Addgene ID: 113192) were
deposited to Addgene.
Bacterial Mutagenesis
Suicide vector pDMK3 was used for generating in-frame
deletions as reported previously (Lindgren et al., 2007; Brodmann
et al., 2017), except that an optimized conjugation procedure
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 August 2018 | Volume 8 | Article 284
Brodmann et al. Plasmids for Francisella novicida
was used (described below). Various genes were cloned into
pKK289Km using NdeI and EcoRI or SacI restriction sites and
into pFNMB1 and pFNMB2 using MluI and SacI restriction
sites. Plasmids, remaining peptides of in-frame deletions and
primers are listed in Supplementary Table 3. Cloning products
were sequenced and the site of homologous recombination was
verified by PCR with primers located outside of the replaced
regions.
pKK289Km and derivatives were transformed by
electroporation as reported previously (Maier et al., 2004).
Up to 1 µg of plasmid was used for electroporation. pFNMB1,
pFNMB2 and derivatives were mobilized by conjugation as
described below.
Conjugation
F. novicida was grown on BHI agar plates supplemented with
0.2 % L-cysteine and 100µg/ml ampicillin and the donor
E. coli strain (kind gift of A. Harms and C. Dehio, Harms
et al., 2017) harboring the plasmid of interest was grown
on Luria-Bertani (LB) agar plates supplemented with 300µM
2,6-Diaminopimelic acid (Sigma) and 50µg/ml kanamycin.
Both plates were incubated over night at 37◦C. The following
day, about 100 µl of F. novicida and E. coli dense bacterial
cultures were transferred to a fresh LB plate supplemented
with 300µM 2,6-Diaminopimelic acid and mixed thoroughly.
After 2 h incubation at 37◦C, about 50 µl of the mixture
was resuspended in 100 µl Mueller–Hinton (MH) broth and
plated on MH agar plates supplemented with 0.1% L-cysteine,
0.1% D-glucose (Millipore), 0.1% FCS (BioConcept), 100µg/ml
ampicillin, and 15µg/ml kanamycin and incubated for 2 days at
37◦C. Single F. novicida colonies were purified by passaging on
selective plates.
To assess conjugation efficiency, the donor and recipient
strains were first concentrated to an OD600 of 10 and then mixed
in a 1 to 1 ratio (each 50 µl). Five microliters of the mixture
was spotted on a LB agar plate supplemented with 300µM
2,6-Diaminopimelic acid in two technical replicates. After 2 h,
the spots were cut out and resuspended in 100 µl of MH
broth. The resuspended bacteria were plated on MH agar plates
supplemented with 0.1% L-cysteine, 0.1% D-glucose, 0.1% FCS,
100µg/ml ampicillin, and 15µg/ml kanamycin. The CFU per ml
and the conjugation efficiency were calculated in the following
manner:
Transformants (
CFU
ml
) =
average coloniescounted
0.1ml
Conjugation efficency =
calculated transformants
used donor cells
The assay was performed in three biological replicates.
Plasmid Stability Assay
On day 0, F. novicida harboring pFNMB1 msfgfp or pFNMB2
msfgfp were diluted to an OD600 of 0.02 and grown in liquid
overnight (ON) cultures supplemented with 15µg/ml kanamycin
and 500 ng/ml ATc to induce gene expression. On days 1–4,
the old ON cultures were diluted to an OD600 of 0.02 and
supplemented with 100µg/ml ampicillin and 500 ng/ml ATc. For
every ON culture, OD600 was measured and aliquots were taken
for imaging, serial dilutions and inoculation of new ON cultures.
Serial dilutions were plated on MH agar plates supplemented
with 0.1% L-cysteine, 0.1% D-glucose, 0.1% FCS, and 100µg/ml
ampicillin and on MH agar plates supplemented with 0.1% L-
cysteine, 0.1% D-glucose, 0.1% FCS, and 100µg/ml ampicillin
and 15µg/ml kanamycin. Colony forming units (CFU) were
counted and the concentrations of CFU/ml were calculated.
Number of generations were calculated with following formula:
N0 = calculated concentration of bacteria used for inoculation
N = calculated concentration of bacteria after serial dilution
Number of generations n =
log NN0
log 2
The experiment was carried out in three biological replicates.
Plasmid Recovery
pFNMB1 msfgfp and pFNMB2 msfgfp were recovered from F.
novicida with a Zyppy Plasmid Miniprep Kit (Zymo Research)
after passaging the cultures for 4 days in liquid BHI supplemented
with 100µg/ml ampicillin and 500 ng/ml ATc as described above.
About 250 ng of each plasmid DNA was then transformed
into chemo-competent E. coli DH5α λpir. The transformed E.
coli were plated on LB agar plates supplemented with 50µg/ml
kanamycin. Three independent experiments were carried out.
The next day, colonies were grown in liquid LB supplemented
with 50µg/ml kanamycin, plasmid DNA was isolated and 250 ng
of each plasmid was digested with SacI-HF and SpeI restriction
enzymes (New England BioLabs) for 1 h. As control, both
plasmids were additionally isolated from E. coli directly, without
passaging in F. novicida, and digested identically. After heat
inactivation of the enzymes (80◦C for 20min), the digested
plasmids were loaded on a 1% agarose gel (BioConcept) together
with a 1 kb ladder (New England BioLabs). DNA was stained
with RedSafe (iNtRONBiotechnology) and a Red imaging system
(Alpha Innotech) was used for imaging.
Fluorescence Microscopy
Microscope set up was described previously (Kudryashev et al.,
2015; Vettiger and Basler, 2016; Brodmann et al., 2017). F.
novicida strains were prepared as described in Brodmann et al.
(2017). For assessment of plasmid stability, 1.5 µl ON culture
was spotted on a pad of 1% agarose in phosphate buffered
saline (PBS) and imaged immediately. For measuring the GFP
signal intensities after induction with ATc, the spotted bacteria
were imaged immediately. For assessing T6SS function of
complemented in-frame deletion mutants, the bacteria were
incubated on a pad at 37◦C for 1 h before imaging. All imaging
experiments were performed in three independent experiments.
Image Analysis
Image analysis and manipulations were performed with Fiji
software (Schindelin et al., 2012) as described previously (Basler
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et al., 2013; Vettiger and Basler, 2016). For calculation of the GFP
signal intensities after ATc induction, the background intensity
was subtracted with the plugin “BackgroundSubstracter.” Then
the plugin “Time Series Analyzer V3.0” was used to quantify
the total GFP signal intensity of the whole field of view.
The total GFP signal intensity was divided by the number of
bacteria in the field of view. Number of bacteria was calculated
with the “Find Maxima” function from phase contrast images.
Contrast on compared images was adjusted equally. For the
Supplementary Movies, the contrast used for F. novicida U112
1iglC pFNMB2 iglC induced with 500 ng/ml was set to match
the other strains.
Cell Culture and Infection Assay
The day before infection experiment, bone marrow derived
macrophages (BMDMs) were seeded into 96-well plates
(Eppendorf) at a density of 5∗104 cells/well in DMEM
(Thermo Fisher) with 20% M-CSF (supernatant of L929
mouse fibroblasts, BioConcept), 10% FCS (BioConcept), 10mM
HEPES (BioConcept), and non-essential amino acids (Thermo
Fisher). The BMDMs were primed with 100 ng/ml LPS from
E. coli O111:B4 (InvivoGen). F. novicida strains were grown
aerobically in liquid BHI culture supplemented with the
corresponding antibiotics and with 0 or 500 ng/ml ATc at 37◦C
ON. The next day, the medium of the BMDMs was replaced with
fresh medium supplemented with 0 or 1,000 ng/ml ATc and the
bacteria were added to the BMDMs at a multiplicity of infection
(MOI) of 100. The 96-well plates were centrifuged at 300 g
for 5min to synchronize the infection process and afterwards
incubated at 37◦C. After 2 h, the medium was replaced with
fresh medium supplemented with 0 or 1,000 ng/ml ATC and
with 10µg/ml gentamycin (BioConcept). Then the 96-well
plates were incubated for 10 h at 37◦C. Afterwards, a lactate
dehydrogenase (LDH) release assay was carried out with an LDH
Cytotoxicity Detection Kit (Takara). The percentage of LDH
release was calculated with the following formula:
% of LDH release =
LDH valueinfected − LDH value uninfected
LDH valuetotal lysis − LDH value uninfected
×100
Infection experiments were carried out in biological triplicates.
The unpaired two-tailed t-test with Welch’s correction was used
to identify significant differences. P-values are given in the figure
legend.
RESULTS
The need for expression plasmids for F. novicida, motivated us
to construct the mobilizable and inducible expression plasmids
pFNMB1 and pFNMB2 (Figure 1C). We constructed pFNMB1
and pFNMB2 by using the backbone of pKK289Km, which is
transformed by electroporation and contains a constitutively active
promoter groESL (Bönquist et al., 2008). As electroporation can be
difficult in F. novicida (Maier et al., 2004; LoVullo et al., 2006),
the need for electroporation was circumvented by inserting the RP4
mobilization site of pDMK3 (Lindgren et al., 2013) encoding traI
(relaxase), traX (regulation of traI and traJ), traJ, and traK (oriT
binding proteins) and origin of transfer (oriT) (Haase et al., 1995)
at the site of the truncated chloramphenicol resistance cassette.
The constitutively active groESL promoter was exchanged for the
tetracycline inducible grotet promoter (LoVullo et al., 2012). Two
different RBS were inserted to achieve a wider range of expression
levels. pFNMB1 was designed for lower expression and contains the
ribosomal binding site (RBS) of iglC in front of a MluI restriction
site. Higher expression levels in pFNMB2 were reached by inserting
the RBS of pKK289Km in front of a MluI restriction site. In addition,
the well characterized E. coli rrnB T1 and T2 terminators from pBAD
(Guzman et al., 1995) were inserted after a multiple cloning site.
First, we tested the conjugation efficiency of pFNMB1 msfgfp
from an E. coli strain harboring a chromosomally encoded RP4
machinery (Harms et al., 2017) to F. novicida. Both strains were
mixed in a 1:1 ratio and spotted on an agar plate. After 2 h incubation
at 37◦C, the bacteria were resuspended and plated on agar plates
containing both ampicillin and kanamycin to select for F. novicida
harboring the plasmid. On average, about 5.1∗10−7 ± 2.5∗10−7
bacterial cells were transformed per donor cell.
As plasmid instability is reported for certain Francisella plasmids
(Pomerantsev et al., 2001b; Maier et al., 2004), we tested the stability
of pFNMB1 and pFNMB2 with msfgfp in F. novicida over 4 days
by inducing expression with 500 ng/ml ATc but without addition of
kanamycin to select for plasmid maintenance (Figure 2). To assess
plasmid stability, we monitored msfGFP expression by fluorescence
microscopy (Figures 2A,B) and counted the kanamycin resistant
colonies (Figure 2C). Over 4 days and during ∼40 generations,
the plasmids were stable in the bacterial population. Importantly
both, the msfgfp and the kanamycin resistance cassette, which
are located at different sites on the plasmid (Figure 1C), stayed
fully functional. To exclude that the plasmids integrated into the
chromosome, pFNMB1 msgfp and pFNMB2 msfgfp were recovered
from F. novicida after passaging the bacteria for 4 days as described
above. Then the isolated plasmid DNA was transformed into E. coli.
The plasmids were recovered again, digested with SacI and SpeI
restriction enzymes and loaded on an agarose gel to analyze the
size of the DNA fragments. Two bands of the correct size (about
6,000 base pairs and 1,700 base pairs) were observed for pFNMB1
msfgfp and pFNMB2 msfgfp similarly to the controls pFNMB1
msfgfp and pFNMB2 msfgfp, which were not passaged in F. novicida
(Figures 2D,E). These results strongly suggest that the plasmids
are maintained extra-chromosomally in F. novicida without any
rearrangements.
To test if the grotet promoters of pFNMB1 and pFNMB2 respond
to ATc in F. novicida, we used different ATc concentrations to
induce expression of msfGFP (Figure 3). Indeed, msfGFP intensity
increased in a concentration dependent manner for both plasmids.
However, the level of induction differed; GFP expression from
pFNMB1 was in general lower than from pFNMB2 (Figure 3D)
indicating that the pKK289KmRBS starts translationmore efficiently
than the iglC RBS. Furthermore, we compared GFP expression from
pFNMB1, pFNMB2 and pKK289Km by fluorescence microscopy
(Figures 3A–C). Interestingly, bacteria harboring pKK289Km gfp
showed a heterogeneous expression of GFP (Figure 3C), while all
bacteria harboring pFNMB1 msfgfp or pFNMB2 msfgfp expressed
similar levels of GFP after induction with 500 ng/ml ATc. Without
ATc, no GFP fluorescence was observed indicating that expression
is well repressed by the TetR in the absence of ATc (Figures 3A,B).
However, GFP expression was higher in some bacteria containing
pKK289Km plasmid than in those with pFNMB1 and pFNMB2
(Figures 3A–C).
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FIGURE 2 | Plasmid stability. GFP expression was induced with 500 ng/ml of ATc. ON culture of day 0 was supplemented with 15µg/ml kanamycin, while ON
cultures of days 1–4 were supplemented with 50µg/ml ampicillin. (A) GFP expression in F. novicida U112 pFNMB1 msfgfp ON cultures of day 0 and day 4. (B) GFP
expression in F. novicida U112 pFNMB2 msfgfp ON cultures of day 0 and day 4. (A,B) Images are a merge of phase contrast and GFP channel. 26 × 39µm fields of
view are shown. Scale bar represent 5µm. Representative replicates are shown. Three independent experiments were performed. (C) Survival assay performed with
ON cultures of F. novicida U112 pFNMB1 msfgfp and F. novicida U112 pFNMB2 msfgfp plated on ampicillin and ampicillin/kanamycin plates. Three independent
experiments were performed. (D) Digestion of pFNMB1 msfgfp with SacI and SpeI restriction enzymes. (E) Digestion of pFNMB2 msfgfp with SacI and SpeI restriction
enzymes. (D,E) Plasmids were passaged in F. novicida for 4 days before being transformed into E. coli. Controls were isolated directly from E. coli. Representative
replicates are shown. Three independent experiments were performed.
FIGURE 3 | GFP intensities of pFNMB1 msfgfp, pFNMB2 msfgfp, and pKK289Km gfp. (A) Homogeneous GFP expression in F. novicida U112 pFNMB1 msfgfp upon
induction with 500 ng/ml ATc. (B) Homogeneous GFP expression in F. novicida U112 pFNMB2 msfgfp upon induction with 500 ng/ml ATc. (C) Heterogeneous GFP
expression in F. novicida U112 pKK289Km gfp. (A–C) GFP expression was induced with 0 ng/ml ATc and 500 ng/ml of ATc. GFP channels are shown. 39 × 26µm
fields of view. Scale bars represent 5µm. (D) GFP expression in F. novicida U112 pFNMB1 msfgfp and F. novicida U112 pFNMB2 msfgfp was induced with 0, 25,
100, 250, 500, and 1,000 ng/ml of ATc. GFP intensity per bacterium was calculated as described in the section Materials and Methods. Three independent
experiments were performed. Standard deviations are shown.
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In our previous study, we constructed several in-frame deletion
mutants in F. novicida and assessed T6SS function using fluorescence
microscopy (Brodmann et al., 2017). For two mutants (1iglF and
1iglI) with abolished T6SS function, we were unable to exclude
polar effects as the deletion of the downstream genes (iglG and
iglJ) resulted in similar phenotypes. Here, we generated F. novicida
mutants carrying the respective complementation plasmids and
successfully restored T6SS sheath assembly in 1iglF and 1iglI
mutants by expression of IglF or IglI from pFNMB1 after induction
with 250 ng/ml ATc (Figures 4C,D, Supplementary Movies 1, 2).
Importantly, independently isolated colonies exhibited the same
phenotypes. This was in contrast with several problems we
experienced when using pKK289Km plasmid. First, electroporation
of pKK289Km was very inefficient, as we routinely obtained only 1–
10 transformed colonies even when using 1 µg of the plasmid DNA
and 3∗1010 F. novicida cells. In addition, independently isolated
colonies exhibited different phenotypes such as no complementation,
partial complementation or we only detected IglA-GFP aggregates
in cells (Figures 4A,B, Supplementary Movies 1, 2) suggesting
spontaneous deletions or variable expression levels. As previously
characterized (Brodmann et al., 2017), T6SS dynamics in F. novicida
consists of assembly, contraction and disassembly of a long cytosolic
sheath at the bacterial poles and thus non-dynamic GFP aggregates
likely represent non-functional T6SS (Supplementary Movies 1, 2).
We also tested ATc inducible plasmid pEDL17 (LoVullo et al., 2012)
for complementation, however, we failed to obtain any F. novicida
colonies containing the plasmid.
To further test pFNMB1 and pFNMB2 plasmids, we attempted to
restore T6SS function in a 1iglC mutant. The IglC protein is likely
forming the T6SS inner tube, which was shown to be required in a
large copy number in canonical T6SS, e.g., up to ∼1,000 molecules
for a single Vibrio cholerae T6SS sheath-tube complex (Wang et al.,
FIGURE 4 | Complementation of in-frame deletion mutants on agar pads. The first frame of the GFP channel of one of the examples in the Supplementary Movie 2
is shown. T6SS assemblies were distinguished from GFP aggregates by analyzing dynamics in the movies. A maximum of 4 T6SS assemblies (arrow heads) and/or
GFP aggregates (empty arrow heads) are highlighted. 13 × 9.75µm fields of view. Scale bars represent 2µm. (A) T6SS sheath assemblies (arrow heads) in F.
novicida U112 iglA-sfgfp 1iglF pKK289Km iglF colony 1 and GFP aggregates (empty arrow heads) in colony 2 (B) Failed T6SS sheath assembly in F. novicida U112
iglA-sfgfp 1iglI pKK289Km iglI colony 1 and GFP aggregates (empty arrow heads) in colony 2. (C) T6SS sheath assemblies (arrow heads) in F. novicida U112
iglA-sfgfp 1iglF pFNMB1 iglF, IglF expression induced with 250 ng/ml of ATc. (D) T6SS sheath assemblies (arrow heads) in F. novicida U112 iglA-sfgfp 1iglI pFNMB1
iglI, IglI expression induced with 250 ng/ml of ATc. (E) One T6SS sheath assembly (arrow head) and GFP aggregates (empty arrow heads) in F. novicida U112
iglA-sfgfp 1iglC pFNMB1 iglC, IglC expression induced with 500 ng/ml of ATc. (F) T6SS sheath assemblies (arrow heads) and GFP aggregates (empty arrow heads) in
F. novicida U112 iglA-sfgfp 1iglC pFNMB2 iglC, IglC expression induced with 500 ng/ml of ATc.
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2017). As shown on Figure 4E and Supplementary Movies 1, 2,
T6SS sheath dynamics was only partially restored when inducing
IglC expression from pFNMB1 with 500 ng/ml of ATc. However,
T6SS sheath dynamics was restored to the levels similar to
the parental strain when using pFNMB2 for IglC expression
(Figure 4F, Supplementary Movies 1, 2). Overall, this suggests that
pFNMB plasmids are superior to the previously used plasmids for
complementation in F. novicida and that pFNMB2 plasmid can be
used to achieve high levels of protein expression.
Intracellular F. novicida require a functional T6SS to escape
from the phagosome in order to reach the replicative niche in
the cytosol (Chong and Celli, 2010). Cytosolic F. novicida bacteria
activate the absent in melanoma 2 (AIM2) inflammasome among
other defense mechanisms, which leads to pyroptotic cell death
and pro-inflammatory cytokine release (Fernandes-Alnemri et al.,
2010; Jones et al., 2010). To test whether pFNMB1 can be used for
complementation in bone marrow derived macrophages (BMDMs),
we analyzed in-frame deletion mutant 1iglI and the respective
complemented strain for induction of pyroptosis in infected cells
as a measure for phagosomal escape and thus T6SS function. We
pre-induced expression of IglI from pFNMB1 with 0 and 500 ng/ml
ATc overnight and then infected BMDMs, which were supplemented
with 0 and 1,000 ng/ml ATc. After 10 h of infection, we observed
significantly higher cell death for the complemented strain than for
the in-frame deletion mutant without induced gene expression or for
the in-frame deletion mutant without the plasmid (Figure 5). This
result indicates that pFNMB1 can be used to restore T6SS activity in
F. novicidamutant in BMDMs.
DISCUSSION
We generated stable mobilizable expression plasmids pFNMB1 and
pFNMB2 for F. novicida. There are two major advantages using
these plasmids. First, they can be easily mobilized from E. coli
to F. novicida; second, they allow for inducible and homogeneous
expression of inserted genes in-vitro and inside eukaryotic cells.
We modified pKK289Km by insertion of the RP4 mobilization site
as we experienced great difficulties transforming F. novicida by
electroporation similarly to what was reported previously (Maier
et al., 2004; LoVullo et al., 2006). The low electroporation efficiency
in F. novicida is probably caused by the capsule and restriction-
modification systems (Maier et al., 2004; LoVullo et al., 2006;
Frank and Zahrt, 2007; Gallagher et al., 2008). Gallagher et al.
(2008) suggested to first transform plasmid DNA into a F. novicida
strain with all restriction-modification systems deleted and then
use this isolated plasmid DNA to transform wild-type F. novicida.
Importantly, the high efficiency of mobilization of the pFNMB
plasmids can be reached without this step and therefore may allow
for generation of large libraries of mutants and thus facilitate future
screens and selections.
To express genes in a controlled manner, pFNMB1 and pFNMB2
contain a tetracycline inducible promoter system, which was used
for F. tularensis (LoVullo et al., 2012). We could show that
expression levels were dependent on ATc concentration in F.
novicida (Figure 3D). In contrast to F. tularensis (LoVullo et al.,
2012), we observed no growth defects of F. novicida in the presence
of 1,000 ng/ml ATc. However, we noticed that the expression
levels achieved from pKK289Km were higher than those from our
constructs. One possible explanation for the lower induction levels of
FIGURE 5 | Complementation of 1iglI mutant in BMDMs. Release of LDH
from primed BMDMs supplemented with 0 and 1,000 ng/ml ATc 10 h after
infection with F. novicida U112 iglA-sfgfp 1iglI and F. novicida U112 iglA-sfgfp
1iglI pFNMB1 iglI. Bacterial cultures were supplemented with 0 and 500 ng/ml
ATc overnight. Black columns represent conditions without induction by ATc
and gray columns represent conditions with ATc. Means and standard
deviations of nine measurements originating from three biological replicates are
shown. The two-tailed unpaired t-test with Welch’s correction was used to test
significant differences between two groups. ***P < 0.001 and ****P < 0.0001.
pFNMB1 compared to pKK289Km are the different RBS. However,
pFNMB2 has a similar RBS as pKK289Km (except for the MluI
restriction site); therefore, it is also possible that pFNMB2 is still
partially repressed even at 1,000 ng/ml of ATc. This may suggest that
cytosolic concentration of ATc reaches lower level in F. novicida
than in F. tularensis. Indeed, differences in resistance levels toward
tetracycline antibiotics and number of transporters were reported
(Kingry and Petersen, 2014; Sutera et al., 2014). Additionally, in
contrast to pKK289Km, the expression from pFNMB1 and pFNMB2
is homogenous throughout the bacterial population (Figures 3A–C).
The reason for the heterogeneous gene expression from pKK289Km
in F. novicida is unknown; however, spontaneous deletions or
differential activation of the groESL promoter could be responsible.
Other suitable inducible promoter systems are difficult to use
in Francisella. The araBAD promoter requires the uptake of L-
arabinose for induction (Guzman et al., 1995); similarly the lac
promoter requires lactose or isopropyl-β-D-thiogalactopyranosid
(Polisky et al., 1976). Since Francisella lacks the L-arabinose
and lactose degradation pathway (NCBI, RefSeq NC_008601.1,
Larsson et al., 2005), it is questionable if these inducers are
taken up. In addition, Francisella has a unique RNA polymerase
composition with two different α subunits, which may interfere with
promoter recognition of these commonly used inducible promoter
systems subunits (Charity et al., 2007). A glucose repressible
promoter system was described for F. tularensis (Horzempa et al.,
2008), however, since glucose is a common carbon source, the
use of such repressor could be problematic. In addition, a
temperature dependent promoter was constructed for F. tularensis
(Maier et al., 2004). However, since Francisella is an intracellular
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pathogen (Chong and Celli, 2010), many cell culture infections
or in vivo experiments are performed at defined temperature and
temperature shifting is impossible. Overall, the tetracycline inducible
promoter system is likely the best option for F. novicida despite the
apparent suboptimal level of derepression by ATc. Importantly, the
possibility of inducing gene expression in cell culture or in vivo is a
crucial advantage for testing the role of expressed genes during the
pathogenesis of F. novicida.
In summary, we show that pFNMB1 and pFNMB2 are easy
to mobilize into F. novicida and are stably maintained in the
population. The tetracycline inducible promoter system is functional
in F. novicida and can be used to tune gene expression levels.
pFNMB1 and pFNMB2 exhibit homogeneous expression patterns in
a population and can be used to complement chromosomal in-frame
deletions. Overall, pFNMB1 and pFNMB2 may serve as useful tools
for future studies of F. novicida.
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